ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy

Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.
The American Journal of Managed Care

What Would Make Therapy Last? How About 2 Targets Each on B Cells and T Cells?

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...